Comerica Bank Has $8.70 Million Stock Position in Agilent Technologies, Inc. (NYSE:A)

Comerica Bank decreased its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 2.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 59,784 shares of the medical research company’s stock after selling 1,288 shares during the period. Comerica Bank’s holdings in Agilent Technologies were worth $8,699,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Global Retirement Partners LLC raised its holdings in Agilent Technologies by 31.7% during the 4th quarter. Global Retirement Partners LLC now owns 1,905 shares of the medical research company’s stock worth $249,000 after purchasing an additional 459 shares during the last quarter. Oak Thistle LLC raised its holdings in Agilent Technologies by 8.2% during the 4th quarter. Oak Thistle LLC now owns 4,121 shares of the medical research company’s stock worth $573,000 after purchasing an additional 314 shares during the last quarter. DAVENPORT & Co LLC raised its holdings in Agilent Technologies by 77.7% during the 4th quarter. DAVENPORT & Co LLC now owns 4,882 shares of the medical research company’s stock worth $679,000 after purchasing an additional 2,135 shares during the last quarter. Trust Point Inc. bought a new stake in Agilent Technologies during the 4th quarter worth about $336,000. Finally, Leavell Investment Management Inc. bought a new stake in Agilent Technologies during the 4th quarter worth about $243,000.

Insider Activity

In other news, SVP Dominique Grau sold 15,000 shares of the stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $133.28, for a total value of $1,999,200.00. Following the completion of the sale, the senior vice president now owns 49,486 shares of the company’s stock, valued at approximately $6,595,494.08. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In related news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $130.00, for a total value of $254,540.00. Following the sale, the chief executive officer now owns 25,185 shares in the company, valued at approximately $3,274,050. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, SVP Dominique Grau sold 15,000 shares of the stock in a transaction on Monday, June 10th. The shares were sold at an average price of $133.28, for a total value of $1,999,200.00. Following the completion of the sale, the senior vice president now owns 49,486 shares in the company, valued at approximately $6,595,494.08. The disclosure for this sale can be found here. In the last 90 days, insiders sold 18,916 shares of company stock valued at $2,527,860.

Agilent Technologies Stock Down 4.3 %

NYSE:A traded down $6.15 during trading hours on Friday, reaching $136.71. 572,899 shares of the stock were exchanged, compared to its average volume of 1,774,718. Agilent Technologies, Inc. has a twelve month low of $96.80 and a twelve month high of $155.35. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.15 and a quick ratio of 1.64. The firm has a 50 day moving average of $133.55 and a 200 day moving average of $137.81. The stock has a market cap of $39.89 billion, a PE ratio of 33.77, a PEG ratio of 4.81 and a beta of 1.05.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, May 29th. The medical research company reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.19 by $0.03. The firm had revenue of $1.57 billion during the quarter, compared to the consensus estimate of $1.58 billion. Agilent Technologies had a return on equity of 26.25% and a net margin of 18.84%. The business’s revenue was down 8.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.27 EPS. On average, equities analysts expect that Agilent Technologies, Inc. will post 5.24 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, July 24th. Stockholders of record on Tuesday, July 2nd were issued a $0.236 dividend. This represents a $0.94 annualized dividend and a dividend yield of 0.69%. The ex-dividend date was Tuesday, July 2nd. Agilent Technologies’s payout ratio is presently 22.22%.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Evercore ISI upped their price target on Agilent Technologies from $126.00 to $130.00 and gave the company an “in-line” rating in a research note on Tuesday, July 2nd. TD Cowen reaffirmed a “buy” rating and issued a $153.00 price target on shares of Agilent Technologies in a research note on Monday. Citigroup raised Agilent Technologies from a “neutral” rating to a “buy” rating and upped their price target for the company from $135.00 to $150.00 in a research note on Wednesday, July 10th. Bank of America upped their price target on Agilent Technologies from $134.00 to $140.00 and gave the company a “neutral” rating in a research note on Tuesday, June 25th. Finally, Stifel Nicolaus lowered their price target on Agilent Technologies from $163.00 to $151.00 and set a “buy” rating for the company in a research note on Thursday, May 30th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have assigned a buy rating to the company. According to MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and a consensus price target of $138.06.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.